- Home
- AQST vs ITIC Comparison
AQST vs ITIC Comparison
Compare AQST & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | ITIC |
|---|---|---|
| Founded | 2004 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.0M | 431.1M |
| IPO Year | 2007 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AQST | ITIC |
|---|---|---|
| Price | $4.00 | $212.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 10.7K |
| Earning Date | 03-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.91% |
| EPS Growth | N/A | ★ 13.02 |
| EPS | N/A | ★ 18.57 |
| Revenue | $67,430,000.00 | ★ $272,755,000.00 |
| Revenue This Year | $10.08 | N/A |
| Revenue Next Year | $55.46 | N/A |
| P/E Ratio | ★ N/A | $11.58 |
| Revenue Growth | 0.77 | ★ 5.60 |
| 52 Week Low | $2.20 | $190.20 |
| 52 Week High | $7.55 | $288.98 |
Technical Indicators
Market Signals| Indicator | AQST | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 28.20 |
| Support Level | $3.69 | $209.71 |
| Resistance Level | $4.46 | $221.39 |
| Average True Range (ATR) | 0.20 | 5.86 |
| MACD | -0.02 | -0.23 |
| Stochastic Oscillator | 1.85 | 0.00 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.